Désolé, cet article est seulement disponible en EN.
Cliquez pour voir le graph
Connexions
Présentation
Membres
Michael White
Responsable de Structure
Responsable
Projets
Projet Transversal
Publications
Télécharger-
2024Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study., Lancet Child Adolesc Health 2024 Aug; (): .
-
2024Caveolin-1 protects endothelial cells from extensive expansion of transcellular tunnel by stiffening the plasma membrane., Elife 2024 Mar; 12(): .
-
2024Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission., Vaccines (Basel) 2024 Feb; 12(2): .
-
2024Evaluating vector competence for Yellow fever in the Caribbean., Nat Commun 2024 Feb; 15(1): 1236.
-
2024Disease-specific plasma protein profiles in patients with fever after traveling to tropical areas., Eur J Immunol 2024 Feb; (): e2350784.
-
2024PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
-
2023Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil., Lancet Reg Health Am 2023 Jun; 22(): 100511.
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
-
2023Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
+Voir la liste complète de publications